These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21694826)

  • 1. Response to chemoradiatiotherapy in squamous cell carcinoma of the esophagus: evaluation of some prognostic factors.
    Stockeld D; Falkmer U; Falkmer S; Backman L; Granström L; Fagerberg J
    Clin Exp Gastroenterol; 2009; 2():41-7. PubMed ID: 21694826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
    Seitz JF; Perrier H; Monges G; Giovannini M; Gouvernet J
    Gastroenterol Clin Biol; 1995 May; 19(5):465-74. PubMed ID: 7589997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
    Münch S; Pigorsch SU; Feith M; Slotta-Huspenina J; Weichert W; Friess H; Combs SE; Habermehl D
    Radiat Oncol; 2017 Nov; 12(1):182. PubMed ID: 29157271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma.
    Michaud WA; Nichols AC; Mroz EA; Faquin WC; Clark JR; Begum S; Westra WH; Wada H; Busse PM; Ellisen LW; Rocco JW
    Clin Cancer Res; 2009 Mar; 15(5):1645-54. PubMed ID: 19240170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between expressions of Cyclin-D1, EGFR and p53 with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
    Khan H; Gupta S; Husain N; Misra S; Mps N; Jamal N; Ghatak A
    BBA Clin; 2015 Jun; 3():11-7. PubMed ID: 26675419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.
    van den Broek GB; Wildeman M; Rasch CR; Armstrong N; Schuuring E; Begg AC; Looijenga LH; Scheper R; van der Wal JE; Menkema L; van Diest PJ; Balm AJ; van Velthuysen ML; van den Brekel MW
    Int J Cancer; 2009 Jun; 124(11):2643-50. PubMed ID: 19253368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group.
    Bonin SR; Pajak TF; Russell AH; Coia LR; Paris KJ; Flam MS; Sauter ER
    Cancer; 1999 Mar; 85(6):1226-33. PubMed ID: 10189126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus.
    Münch S; Pigorsch SU; Devečka M; Dapper H; Weichert W; Friess H; Braren R; Combs SE; Habermehl D
    Radiat Oncol; 2018 Aug; 13(1):139. PubMed ID: 30068371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
    Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?
    Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ
    Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.
    Rana L; Sharma S; Sood S; Singh B; Gupta MK; Minhas RS; Jhobta A; Bhatia V; Venkat B
    Eur J Radiol Open; 2015; 2():46-54. PubMed ID: 26937435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS; Waelchli L; Bründler MA
    Clin Cancer Res; 2003 Dec; 9(17):6489-96. PubMed ID: 14695153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.
    Forastiere AA; Heitmiller RF; Lee DJ; Zahurak M; Abrams R; Kleinberg L; Watkins S; Yeo CJ; Lillemoe KD; Sitzmann JV; Sharfman W
    Cancer J Sci Am; 1997; 3(3):144-52. PubMed ID: 9161779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation Between Biomarker Candidate Proteins with the Effect of Neoadjuvant Chemoradiation Therapy on Esophageal Squamous Cell Carcinoma.
    Noda M; Okumura H; Uchikado Y; Omoto I; Sasaki K; Kita Y; Mori S; Owaki T; Arigami T; Uenosono Y; Nakajo A; Kijima Y; Ishigami S; Maemura K; Natsugoe S
    Ann Surg Oncol; 2018 Feb; 25(2):449-455. PubMed ID: 29188501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical predictivity of biomarkers of stage III-IV epithelial ovarian cancer in a prospective randomized treatment protocol.
    Silvestrini R; Daidone MG; Veneroni S; Benini E; Scarfone G; Zanaboni F; Villa A; Presti M; Danese S; Bolis G
    Cancer; 1998 Jan; 82(1):159-67. PubMed ID: 9428493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma.
    Szumilo J; Chibowski D; D browski A
    Dis Esophagus; 2000; 13(3):191-7. PubMed ID: 11206631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx.
    Sahoo R; Chittibabu V; Patil G; Rao S; Thakur S; Dhondalay G; Kulkarni AJ; Banerjee A; Ajaikumar BS; Korlimarla A; Nargund A; Niti RN; Gopinath KS; Prabhudesai S; Raghavendra RM
    Oral Oncol; 2009 Dec; 45(12):e216-21. PubMed ID: 19729336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.